Monmouth Junction, NJ, United States of America

Lawrence T Boni

This inventor holds 17 USPTO granted patents and 17 published patent applications, plus 10 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: The Liposome Company, Inc., Transave Limited, Insmed Incorporated. Active years: 1992-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence T Boni. Retrieved from https://idiyas.com/inventor/lawrence-t-boni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 17)

% Patents Active = 100.0

CIPO Patents = 10 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 14

Forward Citations = 625(Granted Patents)

Company Filing History:

8 out of 115

The Liposome Company, Inc.

Years Active: 1992-2017

Loading Chart...

Areas of Expertise:

Sustained Release

Antiinfectives

Drug Formulations

Lipid Systems

Liposomes

Cancer Treatment

Platinum Aggregates

Biologically Active Compounds

Vaccine Development

Pharmaceutical Compositions

Tocopherol Systems

Steroidal Liposomes

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9827317 - Sustained release of antiinfectives (2017-11-28),

2. 9186322 - Platinum aggregates and process for producing the same (2015-11-17),

3. 8802137 - Sustained release of antiinfectives (2014-08-12),

4. 7879351 - High delivery rates for lipid based drug formulations, and methods of treatment thereof (2011-02-01),

5. 7718189 - Sustained release of antiinfectives (2010-05-18),

6. 7544369 - Sustained release of antiinfectives (2009-06-09),

7. 6793912 - Treatment of cancers by inhalation of stable platinum-containing formulations (2004-09-21),

8. 6544549 - Multilamellar coalescence vesicles (MLCV) containing biologically active compounds (2003-04-08),

9. 6207170 - Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes (2001-03-27),

10. 6086851 - Pharmaceutical compositions containing interdigitation-fusion liposomes (2000-07-11),

11. 5820848 - Methods of preparing interdigitation-fusion liposomes and gels which (1998-10-13),

12. 5683715 - Taxane-containing phosphatidylcholine liposomes (1997-11-04),

13. 5616334 - Low toxicity drug-lipid systems (1997-04-01),

14. 5540936 - Method of producing liposomes (1996-07-30),

15. 5415867 - High ratio active agent: lipid complex (1995-05-16),

Title: **Lawrence T. Boni: Innovator in Lipid Anti-Infective Formulations**

Introduction

Lawrence T. Boni is a renowned inventor based in Monmouth Junction, NJ, who has made significant contributions to the field of pharmaceutical formulations. With an impressive portfolio of 17 patents, Boni has focused on developing innovative methods and compositions to improve drug delivery and efficacy, particularly in the treatment of pulmonary infections and cystic fibrosis.

Latest Patents

Among his latest innovations, Boni has patented formulations for the sustained release of anti-infectives. This invention provides lipid anti-infective formulations that are substantially free of anionic lipids, with a lipid to anti-infective ratio ranging from about 1:1 to about 4:1, and a mean average diameter of less than about 1 micron. The method described for preparing these formulations includes an infusion process, allowing for effective treatment regimens for patients suffering from pulmonary infections and cystic fibrosis.

Additionally, Boni has developed a process for producing lipid-complexed active platinum compounds. This invention allows for higher concentrations of cisplatin, a crucial chemotherapy drug, within the lipid composition, enhancing its therapeutic potential. The formulations can be tailored for inhalation or injection, making them versatile for medical applications.

Career Highlights

Throughout his career, Lawrence T. Boni has worked with notable companies in the pharmaceutical sector, including The Liposome Company, Inc. and Transave Limited. His work in these organizations has centered on pioneering advanced formulations that improve drug efficacy, particularly in challenging therapeutic areas.

Collaborations

Boni has collaborated with esteemed professionals in his field, including Brian S. Miller and Andrew S. Janoff. These partnerships have further enriched his research and development endeavors, leading to innovative breakthroughs in lipid-based drug delivery systems.

Conclusion

Lawrence T. Boni's contributions to the field of pharmaceuticals through his 17 patents mark him as a significant innovator in the realm of lipid formulations. His expertise not only enhances treatment options for patients but also sets new standards within the biotechnology industry. As a leading inventor, Boni continues to inspire advancements in drug development and delivery technologies.

Profile summary based on public USPTO records.